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Introduction. This is a study of the epidemiology of family medicine (FM) in three practice pop-
ulations from the Netherlands, Malta and Serbia. Incidence and prevalence rates, especially of
reasons for encounter (RfEs) and episode labels, are compared.
Methodology. Participating family doctors (FDs) recorded details of all their patient contacts in an
episode of care (EoC) structure using electronic patient records based on the International Classifica-
tion of Primary Care (ICPC), collecting data on all elements of the doctor–patient encounter. RfEs pre-
sented by the patient, all FD interventions and the diagnostic labels (EoCs labels) recorded for each
encounter were classified with ICPC (ICPC-2-E in Malta and Serbia and ICPC-1 in the Netherlands).
Results. The content of family practice in the three population databases, incidence and preva-
lence rates of the common top 20 RfEs and EoCs in the three databases are given.
Conclusions. Data that are collected with an episode-based model define incidence and preva-
lence rates much more precisely. Incidence and prevalence rates reflect the content of the doc-
tor–patient encounter in FM but only from a superficial perspective. However, we found evidence
of an international FM core content and a local FM content reflected by important similarities in
such distributions. FM is a complex discipline, and the reduction of the content of a consultation
into one or more medical diagnoses, ignoring the patient’s RfE, is a coarse reduction, which lacks
power to fully characterize a population’s health care needs. In fact, RfE distributions seem to be
more consistent between populations than distributions of EoCs are, in many respects.
Keywords. Epidemiology, episode of care, electronic medical record, electronic patient record,
family medicine, general practice, ICPC, incidence, international, International Classification
of Primary Care, longitudinal, Malta, person-centred care, prevalence, reason for encounter,
Serbia, the Netherlands, Transition Project.
Introduction
The development of family medicine (FM, synonymous
with general practice) as a clinical speciality and an
academic discipline is informed and enhanced by the
collection of empirical longitudinal data from routine
clinical practice. The study of the epidemiology of FM
using electronic medical record (EMR) databases is
a classic example, recommended by the European Re-
search Agenda for Primary Health Care and General
Practice for empirically and longitudinally measuring
the content of actual practice and patient outcomes
283
D
ow
nloaded from
 https://academ
ic.oup.com
/fam
pra/article-abstract/29/3/283/462210 by U
niversity of M
alta user on 02 August 2019
and informing the domains of research, education, pol-
icy and clinical practice.1,2
Such data allow research into the ‘international dis-
cipline of FM’, a fundamental premise for the exis-
tence of the World Organisation of Family Doctors
(Wonca).3 Although many authors have studied FM
in national and international studies, few international
comparisons studied the actual core content of family
practice. Patients’ symptoms and the diagnostic pro-
cess have been studied even less than morbidity patterns
and interventions.1,2,4–10 Thus, there are important gaps
in our understanding of the international core content
of FM.
The importance of morbidity registration, the col-
lection of routine data from FM and research into the
process of diagnosis has been amply illustrated by the
seminal work of Henk Lamberts and Maurice
Wood,4,5,11 emphasized by the Institute of Medicine’s
(IOM) Report on the Future of Primary Care in the
United States of America6 and more recently by the
European General Practice Research Network’s
(EGPRN) European research agenda for FM.2,7 The
developing field of decision support systems for medi-
cal diagnosis depends on the availability of such data.
A number of longitudinal EMR datasets collected
from the daily practice of family doctors (FDs, synony-
mous with GPs) are available to researchers, including
large databases collected from the Netherlands, the
UK and Australia. Most of these databases collect in-
formation on diagnosis and are encounter-based. How-
ever, practices providing such data are not necessarily
representative of all practices within a geographical re-
gion or health care system.1 Inter-doctor and inter-prac-
tice variations have effects which should be considered
in the interpretation of such data.10,12 Few projects sys-
tematically collect data on the patient’s ‘reason for
encounter’ (RfE; see Methodology) and structure data
in the form of ‘episodes of care’ (EoCs; see Methodol-
ogy).13 Such data elements would allow the structuring
of data within an appropriate ordering principle and
greatly enhance their usefulness for research. As we
have demonstrated previously, data that are not col-
lected within an episode-based model are less able to
precisely characterize incidence and prevalence rates.14
A notable exception is the set of databases collected
by The Transition Project (www.transitieproject.nl),9
a foundation set up in the Netherlands by Henk Lam-
berts and collaborators to study the epidemiology of
EoCs in FM. The project collects data from partici-
pant practices through a specially designed EMR,
where doctors record details of patients’ RfEs, their
interventions and the diagnostic titles of EoCs, within
an EoC data structure. The Transition Project data-
bases thus fulfil the recommendations of the interna-
tional standard for data collection in primary health
care, the ‘International Classification of Primary Care’
(ICPC) and have therefore been used for this study.11
ICPC acts as an ordering principle for FM data, al-
lowing for direct comparisons, and also has the appro-
priate granularity for primary care.14 Data have been
collected in the Netherlands, Japan, Poland, Malta, Ser-
bia and other countries1,4,8,9,15,16 from the daily practice
of a cohort of FDs using similar methodology over a pe-
riod of time (from 1 to 11 years). These data allow the
calculation of incidence and prevalence rates per 1000
patient years of observation in a population, this being
a controlled denominator independent of consultation
rates. The datasets from the Netherlands, Malta and
Serbia have been used for this study since they are
available and validated, recent and overlap in time.
This study aims to support the academic develop-
ment of FM through the analysis of the epidemiology
of FM using a set of longitudinal clinical databases,
collected as part of the Transition Project.9 This paper
shall focus particularly on incidence and prevalence
rates of RfEs and episode titles.
In view of the significant socio-cultural, economic
and health care system differences between the three
countries involved (see below), it is to be expected
that patient needs and disease patterns will be differ-
ent between these patient populations.2,10,17 However,
the local core content of FM in these countries could
be expected to be similar, due to the influence of an
international discipline of FM. The study of similari-
ties and differences in these practice populations thus
informs the discussion on the existence of an interna-
tional academic base for FM as a clinical discipline.
Research questions
 What is the content of general practice/FM as char-
acterized by databases collected from the routine
care of selected practice populations in Malta, the
Netherlands and Serbia and as characterized by
the distributions of RfEs, interventions and diag-
noses within EoCs?
 What are potential explanations for apparent simi-
larities and differences in the distributions of RfEs,
interventions and diagnoses, within EoCs in these
practice populations?
 Notwithstanding such differences, if any, what are
the generic similarities in the content and practice
of general practice/FM in these practice popula-
tions and do these similarities support the exis-
tence of an international discipline of FM?
Methodology
Setting
The Maltese health care system provides publicly fi-
nanced primary and secondary care free at the point
of use. It is an integrated national health service, sup-
plemented by a strong private health care sector. Par-
liament enacts health care legislation and approves
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the health care budget, while the Ministry of Health
acts as a regulator.
The Maltese FD typically works single-handed in
private practice, charging a fee for service or less com-
monly as a salaried member of a group practice man-
ning one of six government health centres. Access to
both private and state systems of PHC delivery is open
to all, and 80% of the population choose the former as
their first choice, even though they still subsidize the
latter through taxation. One of the reasons for this
choice is the improved continuity of care available
when seeing a private FD, but patients often also use
the health centre for repeat prescriptions or minor
complaints. There is currently no formal system for
patient registration with an FD in Malta, but such
a system is under discussion, and FDs have a limited
gatekeeper role.18 The Maltese Transition Project da-
tabase was collected by author JKS from volunteer
self-employed FDs.
The Netherlands has an insurance-funded health care
system, with primary care doctors and other health care
organizations negotiating private contracts and budgets
with various health insurers. The population enjoys
nearly universal health insurance coverage through
a combination of private and public insurance. An oblig-
atory national insurance covers all basic care (primary
and secondary) for all citizens, with subsidies on the pre-
mia available for low-income citizens. While most FDs
currently work in private practice, on a solo basis or in
small group practices, the number of large group practi-
ces is growing. FDs are paid a capitation fee per patient
and a fee per consultation, plus a negotiated reimburse-
ment depending on service costs, number of staff em-
ployed and quality and efficiency indicators. FDs act as
gatekeepers to hospital and specialist care.19 The Dutch
database was collected by authors HL, IO, SO and KvB.
In Serbia, the Transition Project initially collected
data in a collaborative project with the International
Committee of the Red Cross (ICRC) for 1 year (2003)
in the Kraljevo area, near the border with Kosovo. The
region has been contested by different political and reli-
gious groups since the times of the Ottoman Empire.
The region was severely affected by wars at the end of
the 20th century, with the local economy (including
a major car and truck factory) being destroyed by
North Atlantic Treaty Organization bombs, many peo-
ple being killed and a large influx of Serb refugees into
the region from Kosovo at the end of hostilities. The
region is relatively poorer than Malta and the Nether-
lands, and people tend to have lower levels of educa-
tion. Around 50 FDs were provided with training,
resources and support by the ICRC and given money
to develop an EMR system based on ICPC. This
project ran for 3 years to kick start primary care in
Serbia and especially in the Kraljevo region. Single-
handed FDs, most with a practice nurse, were specially
recruited for the programme rather than volunteered
for research purposes as in Malta and the Nether-
lands.20,21 Residents >15 years of age were registered
with the FDs, who cared for all health problems except
gynaecology. The Serb database was collected by a team
including authors PZ and MJ.
Data
The public domain EMR TransHis,22 designed for use
with ICPC, was used to collect data from participating
FDs, who recorded details (RfE, diagnosis/es and in-
tervention/s) of all their patient contacts in an EoC
structure using ICPC. RfEs presented by the patient,
all FD interventions and the diagnostic labels re-
corded for each encounter were classified with ICPC
(ICPC-2-E in Malta and Serbia and ICPC-1 in the
Netherlands).
Data elements
The content of family practice is expected to differ
more due to system effects and less due to actual inter-
doctor variation.10,12 For the purposes of this study,
FM content is measured according to an international
standard, the ICPC, as described below.11
An EoC is defined as a health problem from its first
presentation by the patient to the FD, until the com-
pletion of the last encounter for it. It encompasses all
contact elements related to that health problem. Its
name (i.e. the diagnostic label of the EoC) may be
modified over time, and in this article, we refer to it
as the ‘episode title’. The last diagnosis made during
an EoC is the current episode title.9,11
The RfE(s) is defined as an agreed statement of the
reason(s) why a person enters the health care system,
representing the demand for care by that person. The
RfE should be recognized by the patient as an accept-
able description of the demand for care.9,11 Doctors
recording data for the Transition Project were trained
to record RfEs according to the definitions above, re-
flecting the patient’s understanding as expressed.
Symptoms elicited during history taking (i.e. history
of the presenting complaint) were recorded in a sepa-
rate cell in the EMR Transhis and were not used for
the analyses in this study.
ICPC has a biaxial structure, with 17 chapters on one
axis and 7 components on the other. Chapters are based
on body systems, with an additional chapter for psycho-
logical problems and one for social problems.11 Each
chapter is identified by a single alphabetic code, which
is the first character of all rubrics belonging to that
chapter. Each chapter is divided into seven components,
identified by a range of two digit numeric codes.
Component 1 codes symptoms and complaints, while
Component 7 codes diseases. A RfE can be either
a symptom (Component 1) or a disease (Component 7)
when a patient presents with the RfE such as ‘doctor,
I have migraine’. Conversely, an EoC may have a dis-
ease label diagnostic title or it may be labelled with
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a Component 1 ‘symptom’ diagnosis, such as when the
FD cannot be more precise than label an EoC with the
title ‘shortness of breath’. Components 2–6 deal with
interventions and can be used to code an RfE that is
presented as a request for an intervention.11
Population and databases
The databases encompass a defined time period: an
average of 9896 patients and 43 577 patient years of
observation over 5 years in Malta (2001–2005), 15 318
patients and 158 370 patient years over 11 years in the
Netherlands (1995–2005), 72 673 patient years over
1 year in Serbia (2003). The practice populations in
the Netherlands and Serbia represent registered pa-
tient populations (the Serbs only those >15 years of
age), while the population in Malta represents patients
consulting over a 5-year period. The databases were
analysed using a 1-year data frame. An EoC open over
a number of years of observation would be re-coded as
rest-prevalent (to distinguish it from new) in subse-
quent years, but only for those years when a consulta-
tion for that same EoC occurred.
Analysis
The databases were used to calculate population char-
acteristics, utilization rates and incidence and preva-
lence rates for both RfEs and EoCs. Interventions
were analysed as aggregated rates, and not by individ-
ual codes, since the distribution of such codes is very
narrow (in fact, >90% of interventions in the Dutch
database are described by only five codes).9 Distribu-
tions of ICPC utilization, population demographics and
an extended comparison of incidence and prevalence
rates for less common diseases were also analysed. The
data included is an example of the extensive data,
which can be output from the Transition Project, lim-
ited to these sets in the interest of brevity.
All encounter data (face-to-face encounters in the of-
fice and at home, telephone consultations, repeat pre-
scriptions, etc.) were analysed to obtain complete data
on incidence and prevalence, including patients present-
ing for a repeat prescription only. All prescriptions were
coded with the Anatomical Therapeutic and Chemical
(ATC)23 and ICPC drug classifications [including infor-
mation on prescribed defined daily doses (DDDs)].
Rates are presented as ‘number of observations per
thousand person (patient) years of observation’. A pa-
tient year starts when a patient registers in the practice
and is closed when the patient leaves the practice for
any reason, including death. In the case of Malta,
where patients are not registered with the FD, but
tend to see the same FD for most, but possibly not
all, health care problems, a patient year was opened
when a patient presented to the FD for an encounter.
Any patients in the Maltese database who did not con-
sult in the observation period of 5 years did not con-
tribute to the denominator.
Incidence rates in this study give the rate of an ob-
servation in new EoCs, i.e. at an encounter at the start
of a new EoC, per thousand patient years of observa-
tion. Prevalence rates give the rate of an observation
in all EoCs, both incident and rest-prevalent consid-
ered together, in that period of observation. Rest-
prevalent EoCs represent a health problem that is not
new but has presented during a period of observation
for follow up of that problem. A patient can have
more than one new EoC for the same diagnosis during
an observation period (say two separate EoCs for
bronchitis in 1 year) and/or may present with the same
RfE more than once in an observation period. How-
ever, the same RfE cannot be coded more than once
per encounter per EoC.
Rates of RfEs and EoCs were standardized to the Eu-
ropean Union standard 25 country population (EU25
population)24 to adjust for age and sex differences in
the practice populations under study. Age was calcu-
lated at the middle of the observation frame (middle of
each year of observation and 1 year data frame). The
practice populations were treated as defined populations
and not as samples of a larger population.
The distributions were ranked according to new
RfEs (new presentations of symptoms and requests)
and all EoC titles (the ‘burden of disease’ and health
problems in these populations), to include the joint
top 20 ranks in all three populations. The largest
(Dutch) database was used to rank the tables.
Ethical approval
The study did not involve the collection of new data.
Ethical approval was applied for locally, when appro-
priate, for individual studies based on these data in
the Netherlands, Serbia and Malta.
Results
We would suggest that a printed copy of all ICPC ru-
brics and short text labels might be useful while
reading the results and discussion sections below.
Such two-page documents are freely available in
many languages from the Wonca website (http://
www.globalfamilydoctor.com/wicc/pagers.html).
Databases
Table 1 gives the characteristics of the three population
databases and illustrates their considerable size and de-
tail. Empty cells represent data, which are missing or
not available, reflecting practical difficulties in extract-
ing prescription, referral and test result data from the
custom Serb EMR, and test results from Malta. The
Dutch database is largest, with >1.3 million RfEs and
over half a million EoCs in 850 000 encounters, and it
covers the widest time interval. There are proportion-
ately less subencounters and new EoCs in the Serb
Family Practice—The International Journal for Research in Primary Care286
D
ow
nloaded from
 https://academ
ic.oup.com
/fam
pra/article-abstract/29/3/283/462210 by U
niversity of M
alta user on 02 August 2019
database, which is also notable in that it includes more
individual patients (72 673) and represents data from
50 FD practices.
Population age–sex distributions
Figure 1 gives the cumulative age–sex distributions of
the populations under study (numbers of patients in
an age–sex band for each cumulative year of observa-
tion). The Serb population exhibits a shift towards
more females and less children.
Denominator and utilization
Table 2 gives derived (calculated) parameters of the
three population databases. The average patient popu-
lation in the three databases is calculated to be 15 318
Dutch, 9896 Maltese and 72 673 Serb patients. The
number of patient years of observation is slightly less
than the number of patients for each database, except
for the Serb figure for 1 year of observation.
The Maltese database contains relatively fewer en-
counters per patient year than the others and also fewer
prescriptions than the Dutch, but the rate of suben-
counters per encounter is similar to the Dutch datum.
The Dutch data contain more EoCs and diagnoses per
patient year, and the Dutch FDs tended to code rela-
tively more encounters, RfEs, EoCs, interventions and
prescriptions. The Dutch and Maltese FDs tended to
record multiple RfEs for each new EoC, in contrast to
the Serbs FDs who coded more interventions per year
and per EoC. This trend is also evident in the numbers
of RfEs in general, with Serb doctors tending to record
more RfEs per patient year than their Maltese counter-
parts, but proportionately fewer of those in new, as
against rest-prevalent, EoCs (i.e. those EoCs opened
before a particular year of observation and followed up
during that said year). Referral rates are low, at 1 every
10 patient years in Malta and 4 per 10 patient years in
the Netherlands (primary and secondary care referrals
considered together).
Coding
Table 3 describes coding with ICPC in each of the
three databases. The Dutch FDs used a larger number
of different ICPC rubrics in coding both RfEs and
EoCs and used almost all the available ICPC rubrics
at least once between them, including ICPC drug clas-
ses across prescribed drugs. The Maltese FDs also
demonstrated broad utilization of rubrics, in contrast
to the Serb FDs. With regards to coding RfEs, the 20
most utilized rubrics in the Dutch and Maltese data-
bases (the top 20) cover around two-thirds of the en-
tire distribution of presented RfEs. The Serb data are
less diverse, with >80% of all RfEs being coded by 20
rubrics. The situation is slightly different with EoCs,
where the Dutch again exhibit the widest diversity
(the top 20 rubrics used for EoCs only cover one-third
of the distribution), while the Maltese and Serb top 20
rubrics describe just over half of the distribution.
Distribution of RfEs
Table 4 lists the top 20 new RfEs in the three data-
bases. The 20 most commonly coded RfEs in new
EoCs in each of the three databases are presented, i.e.
RfEs in incident EoCs. Thirty-six rubrics are sufficient
to describe the common distribution of the three pop-
ulations.
The Serb rates of incident, but also prevalent, RfEs
tend to be lower than the other two sets, and this will
influence other comparisons. The Serb data also exhibit
less diversity of coding by FDs, as reported above. In
fact, the top 20 rubrics describe a larger proportion of
the general distribution in the Serb data. In particular,
skin problems (Chapter S in ICPC), other localized ab-
dominal pain (D06), earache (H01) and vomiting
(D10) seem to be far less common as Serb RfEs. In
contrast, the prevalence of neck complaints (L01), feel-
ing anxious (P01), respiratory pain and angina (R01
and P01) expressed as symptoms (prevalent RfEs) in
the Serb database appear high in comparison with the
other two populations. In the Netherlands, tiredness
(A04) and low back pain (excluding radiation, L03)
TABLE 1 Characteristics of the three population databases
1 year data frame databases Netherlands Malta Serbia
Observation period 1995–2005 2001–2005 2003
Patients (cumulative over period) 168 497 49 479 72 673
Patient years denominator 158 370 43 577 72 673
Encounters 838 896 70 177 207 323
Subencounters/diagnoses 1 178 178 93 606 405 150
RfEs 1 326 920 131 537 363 520
RfE in new EoCs 422 568 82 224 34 828
EoC 554 804 75 450 103 133
New EoC 337 348 55 821 41 172
Interventions 1 605 345 201 132 387 468
Prescriptions 810 894 54 352 –
Measurements and/or test results 252 812 – –
Referrals primary care 28 822 859 –
Referrals specialist 38 250 3 928 –
Years of observation 11 5 1
Number of doctors 10 9 50
Practices 5 4 50
Empty cells represent data that are missing or not available. ‘Patients
(cumulative over period)’ refers to the average number of patients ob-
served each year in turn, each then summed up for the entire period.
‘Subencounters/diagnoses’ refers to the number of diagnoses dealt
with in subencounters (the part of an encounter which deals with
one single EoC). An encounter may have several subencounters.
‘New EoC’ refers to the epidemiological status of an EoC, a new
EoC being incident in the observation period. An EoC is rest-preva-
lent (‘roll-over’) if it already existed before the observation period
and was followed up within the period. New and rest-prevalent epi-
sodes together thus form the prevalent episodes in a registration pe-
riod, and this total is given in the cell referred to as EoC. ‘Referrals
primary care’ includes referrals to non-specialist colleagues (e.g. phys-
iotherapist, podologist). Other terms are self-explanatory.
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appear to be at least twice as prevalent as in the other
two datasets and incidence is also high. Additionally,
shortness of breath (R02), hearing complains (H02)
and most musculoskeletal RfEs also appear to be
more common in the Dutch database. All respiratory
symptoms and many symptoms associated with acute
viral illness (e.g. fever and gastrointestinal symptoms)
exhibit high incidence and prevalence rates in Malta,
FIGURE 1 Cumulative sex–age distributions of the practice populations in the Netherlands, Malta and Serbia, respectively.
Numbers represent cumulative populations calculated year by year (1-year data frame)
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while epigastric pain (D02) is relatively less common
than may be expected from this general trend.
Requests for interventions were ignored in calculating
these distributions, so as to focus on symptoms rather
than requests for the FD to perform a specific interven-
tion. However, the proportion of RfEs formulated as re-
quests for interventions, which are excluded from the
tabulated data, are given at the foot of Table 4. In the
Serb database, they represent 57% of all RfEs, as
against 38% and 20%, respectively, in the Dutch and
Maltese databases.
Distribution of episode titles
Table 5 lists the top 20 episode titles in the three data-
bases, i.e. the 20 most commonly coded EoCs in each
of the three databases are presented. Episode titles ex-
hibit more diversity than RfEs. In fact, 41 labels are
necessary to describe the top 20 distributions of EoCs,
as against only 36 for RfEs.
In Malta, EoCs for respiratory and other acute viral
illnesses, especially upper respiratory tract infections
(URTI, R74), exhibit relatively higher prevalence and
incidence rates when compared to the other two data-
bases. Gastroenteritis (D73), muscle pains (L18) and
tobacco abuse (P17) are also more prevalent, and inci-
dent, in the Maltese database, while cystitis (U71) is
relatively less common. The Dutch data show remark-
ably high incidence and prevalence rates for EoCs of
family planning/contraception (W11) and sleep distur-
bance (P06), musculoskeletal (L) and skin (S) prob-
lems, ear wax (H81), tiredness (A04) and anxiety
(P01) and slightly less so for cystitis (U71). In the Serb
dataset, there are fewer EoCs of prevention (A98) and
‘no disease’ (A97, usually coding an administrative en-
counter for the filling of paperwork or forms only),
drug adverse effects (A85) and depression (P76) and
fewer skin (ICPC Chapter ‘S’) and respiratory (‘R’)
EoCs. In contrast, there are relatively high rates for
TABLE 2 Derived parameters of the three population databases
Derived parameters Netherlands Malta Serbia
Patients (average/year) 15 318 9896 72 673
Patient years (average/year) 14 397 8715 72 673
Encounters per patient year 5.3 1.6 2.9
Subencounters per encounter 1.4 1.3 2.0
Diagnoses per patient year 7.4 2.1 5.6
New diagnoses per patient year 2.1 1.3 0.6
EoCs per patient year 3.5 1.7 1.4
New EoCs per patient year 2.1 1.3 0.6
RfEs per patient year 8.4 3.0 5.0
RfEs per EoC 2.4 1.7 3.5
New RfEs per patient year 2.7 1.9 0.5
RfEs per new EoC 1.3 1.5 0.8
Interventions per patient year 10.1 4.6 5.3
Interventions per EoC 2.9 2.7 3.8
Primary care referrals per
patient year
0.2 0.0 –
Specialist referrals per patient year 0.2 0.1 –
Prescriptions per patient year 5.1 1.2 –
Prescriptions per EoC 1.5 0.7 –
Empty cells represent data that are missing or not available. ‘Patients
(average per year)’ is the average number of patients listed in the da-
tabase per year of observation (the number of listed patients divided
by the number of years of observation). ‘Patient years (average per
year)’ is the average number of patient years per year of observation.
It is the result of correcting the actual number of listed patients for the
actual time that each listed patient was registered with the practice, so
that a patient year in fact counts 365 days. ‘Encounters per patient
year’ is the number of doctor–patient encounters divided by the num-
ber of patient years. ‘Subencounters per encounter’ represents the av-
erage number of EoCs (diagnoses) managed per doctor–patient
encounter. A subencounter represents the part of an encounter that
deals with one single EoC. An encounter may thus have several sub-
encounters. ‘Diagnoses (synonymous with subencounters in this con-
text) per patient year’ represents the number of diagnostic labels (or
subencounters) per patient year. ‘New’ diagnoses are those incident in
the observation period. ‘EoCs per patient year’ and ‘new EoCs per pa-
tient year’ represent the rate of all EoCs, and new EoCs (respec-
tively), per patient year. ‘RfEs per patient year’ is the rate of RfEs
per patient year, while ‘RfEs per EoC’ is the average number of RfEs
presented per EoC. New RfEs are those that are recorded at the start
of a new (or incident) EoC. The last six rows represent rates of inter-
ventions, referrals and prescriptions per patient year or per EoC.
TABLE 3 ICPC utilization in the three databases
ICPC rubric usage Netherlands (%) Malta (%) Serbia (%)
Number of rubrics as RfEs 711 (98) 594 (82) 470 (65)
Number of rubrics as new RfEs 698 (96) 520 (72) 401 (55)
Number of rubrics as episode titles 684 (100) 618 (90) 610 (89)
Number of rubrics as new EoC titles 680 (99) 589 (86) 594 (87)
Number of rubrics as interventions 38 (100) 40 (100) 40 (100)
Number of ICPC drug classes used 266 188 –
Total Top 20 RfE 875 076 83 395 300 707
%Age of total distribution 65.95 63.40 82.72
Total top 20 EoC 178 516 38 709 57 828
%Age of total distribution 32.18 51.30 56.07
The number of rubrics (codes) used by the participating FDs to code RfEs in all EoCs, RfEs in new EoCs, diagnostic labels in EoCs and new EoCs,
interventions (process) and ICPC drug classes, respectively, are given in the first six rows. The percentages in brackets represent the percentage of
all possible rubrics actually utilized at least once by the group of coding FDs. The next two rows represent the number of RfEs, which are coded by
the 20 most common rubrics in each population, and the percentage these represent from the total distribution of RfEs. The last two rows represent
the number of EoCs coded by the 20 most common rubrics in each population, and the percentage these represent from the total distribution of
EoCs. Note that requests for interventions (RfEs in Components 2–7 of ICPC) were excluded from the calculations of RfE distributions.
289An international comparative FM study of the Transition Project data
D
ow
nloaded from
 https://academ
ic.oup.com
/fam
pra/article-abstract/29/3/283/462210 by U
niversity of M
alta user on 02 August 2019
TABLE 4 The top 20 new RfEs in the three databases
Nl Nl incidence Nl prevalence Mt Mt incidence Mt prevalence Sb Sb incidence Sb prevalence
Rank Code Label p1000py EU 2005 p1000py EU2005 Rank p1000py EU 2005 p1000py EU2005 Rank p1000py EU 2005 p1000py EU 2005
1 R05 Cough 121.8 119.7 164.8 162.2 1 188.9 167.8 243.5 219.5 1 33.7 32.0 164.9 147.4
2 A03 Fever 58.2 55.2 71.5 68.0 4 114.8 92.9 130.6 106.3 12 5.1 5.4 16.4 15.7
3 S06 Local redness/erythema/rash 56.7 56.2 70.6 70.2 10 31.7 30.6 38.2 37.4 39 1.9 1.7 3.7 3.0
4 R21 Symptom/complaint throat 50.6 50.8 61.2 61.5 2 168.0 150.3 184.2 165.0 2 18.6 20.1 55.8 58.4
5 A04 General weakness/tiredness 49.5 49.8 76.4 77.1 14 23.8 26.2 34.0 40.2 17 4.0 3.3 45.5 32.3
6 S04 Local swelling/papule/lump/mass 47.9 48.2 54.9 55.3 20 15.0 15.3 17.7 18.4 33 2.4 2.2 4.7 4.1
7 L03 Low back complaint excl radiation 46.0 46.9 75.6 77.1 34 8.6 9.4 13.3 15.2 14 4.9 3.9 56.7 41.9
8 D06 Other localized abdominal pain 37.9 38.2 60.9 61.6 7 37.9 37.7 50.0 51.9 27 2.7 2.3 8.2 6.4
9 H01 Ear pain/earache 36.1 34.5 43.3 41.4 8 37.8 32.4 42.4 36.5 16 4.2 3.9 11.7 10.4
10 N01 Headache (excl N02 N89 R09) 35.8 36.0 53.2 53.5 9 32.4 30.7 45.0 44.3 6 7.2 6.4 51.4 39.3
11 R02 Shortness of breath dyspnoea 33.0 33.1 71.3 72.0 27 10.3 11.7 21.8 26.4 33 2.4 2.1 20.6 15.5
12 L08 Shoulder symptoms/complaints 31.7 32.4 49.8 50.9 28 9.9 11.5 13.6 16.5 46 1.6 1.4 9.7 7.6
13 L17 Foot and toe symptoms/complaints 31.1 31.5 41.4 42.0 21 14.7 16.8 19.4 23.1 59 1.0 0.9 3.9 3.0
14 L15 Knee symptoms/complaints 30.5 31.1 48.6 49.8 24 12.5 13.9 17.7 20.8 28 2.7 2.3 16.5 12.6
15 S02 Pruritus 29.2 29.3 41.7 42.0 19 16.0 15.2 20.3 19.7 11 5.7 5.1 14.7 11.4
16 R74 URI (head cold) 28.8 28.4 34.4 33.9 40 5.9 5.8 8.0 7.7 111 0.3 0.4 0.6 0.6
17 L01 Neck symptom/complaint excl
headache
28.5 28.8 43.6 44.2 18 16.6 16.5 21.5 22.2 4 8.6 6.9 97.8 68.7
18 L14 Leg/thigh symptoms/complaints 27.8 28.6 45.1 46.5 22 13.4 16.3 20.1 26.1 35 2.2 1.9 15.4 11.5
19 H02 Hearing complaints excl H84) 27.6 27.8 36.4 36.6 51 4.7 5.2 6.1 6.9 36 2.2 1.8 3.6 2.8
20 L04 Chest symptoms/complaints 25.1 25.7 35.4 36.2 16 21.1 24.0 28.1 32.7 26 2.8 2.7 16.2 12.3
21 N17 Vertigo/dizziness 24.1 24.8 38.0 39.0 15 23.8 26.4 34.2 39.3 21 3.4 2.4 14.9 10.2
22 D11 Diarrhoea 22.2 21.9 29.8 29.5 6 41.1 37.7 47.2 44.2 13 5.0 5.1 12.5 12.3
26 U02 Urinary frequency/urgency 17.5 17.8 22.4 22.9 36 7.4 8.3 9.4 10.9 15 4.8 4.0 20.1 14.6
27 U01 Dysuria/painful urination 17.3 17.6 21.5 21.9 25 11.4 11.5 13.6 14.2 9 6.0 4.8 27.0 21.1
28 D09 Nausea 17.1 17.4 24.6 25.0 13 27.0 25.8 33.0 32.4 25 2.9 2.7 9.8 8.3
29 L02 Back symptom/complaint 16.9 17.3 24.8 25.2 12 27.6 29.9 37.1 41.7 5 8.0 7.1 58.0 43.6
34 D10 Vomiting 15.0 14.5 20.0 19.4 5 41.7 35.1 47.2 40.5 42 1.7 1.9 4.6 4.3
35 D01 Abdominal pain/cramps general 14.9 14.7 24.5 24.3 11 29.1 26.7 36.0 34.2 7 6.7 6.2 40.5 33.2
36 P01 Feeling anxious/nervous/tense 14.7 14.9 30.8 31.4 29 9.8 10.8 25.8 29.4 8 6.2 5.0 80.5 58.9
39 F02 Red eye 13.3 13.3 15.3 15.3 26 10.6 9.8 12.3 11.4 18 3.8 3.4 8.2 6.9
41 D02 Abdominal pain epigastric 12.3 12.5 20.6 21.0 58 3.7 4.0 5.6 6.5 10 5.8 4.9 32.1 25.9
53 R07 Sneezing/nasal congestion 9.2 9.2 12.7 12.7 3 135.1 113.8 157.7 133.7 52 1.2 1.2 3.3 3.6
75 S07 Rash generalized 6.0 5.7 7.2 6.9 17 17.0 13.9 20.7 17.0 100 0.3 0.4 0.6 0.6
78 K02 Pressure/tightness of heart 5.5 5.7 10.8 11.2 122 1.1 1.6 2.1 3.2 19 3.5 2.9 69.7 51.7
123 A05 Feeling ill 3.5 3.6 8.6 8.7 154 0.7 0.8 0.9 1.2 20 3.4 2.9 10.4 7.9
129 R01 Pain respiratory system 3.2 3.3 4.5 4.5 82 2.2 2.3 2.9 3.0 3 12.8 11.3 94.4 80.9
36 ranks Total RfE 2–6 (p1000py) 2048.1 3295.3 1549.6 2043.8 281.8 1767.5
Proportion Rfe 2–6 of top 20 distribution (N) Rfe 2–6 T20 RfE RfE 2–6 T20 RfE RfE 2–6 T20 RfE
65 356 170 939 38% 10 745 52 616 20% 13 061 22 815 57%
Nl, Netherlands; Mt, Malta; Sb, Serbia. The 20 most commonly coded RfEs in new EoCs in each of the three databases are presented, i.e. RfEs in incident EoCs, 36 rubrics describing the common distribution of the three populations.
Requests for interventions were ignored in calculating these distributions. The incidence rate (rate of that RfE per 1000 patient years at the beginning of a new EoC) and also the prevalence rate (rate of that RfE per 1000 patient
years at any encounter during an EoC, i.e. all instances of that RfE) of the 36 RfE rubrics (presented as a disease label or symptom, i.e. ICPC Components 1 and 7, requests for interventions not included) are given. Rates are
expressed per 1000 patient years of observation, both unadjusted and also adjusted for age and sex to a standardized EU 25 country population. The ranking of each rate in the three respective populations is given (according
to their rank in incidence), and the rubrics are ranked according to the Dutch distribution (ranking in first column). The proportion that Components 2–6 rubrics (representing requests for interventions which were not included
in this distribution) would contribute to the distribution of the 20 most common new RfEs in each population is also listed for the purpose of comparison. ‘Rank’ gives the rank of that rubric in the distribution of incident (new) RfEs
in that population. ‘Code’ gives the ICPC code. ‘Label’ gives the ICPC-2 text label for that rubric. ‘Incidence’ gives the rate of observation of that rubric as a RfE in new EoCs (both unadjusted and adjusted for age and sex against the
EU-25 population). ‘Prevalence’ gives the rate of observation of that rubric as a RfE in all EoCs (both unadjusted and adjusted for age and sex against the EU-25 population). ‘Total RfE’ gives the total rate of all RfEs (excluding
requests for intervention, Components 2–6 of ICPC), incident and prevalent, per 1000 patient years. ‘Proportion RfE 2–6 of total distribution (N)’ gives the percentage proportion that RfEs formulated as a request for intervention
(‘RfE 2–6’) represent of the entire top 20 new RfEs (‘T20 RfE’).
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TABLE 5 Lists the top 20 EoCs (episode titles) in the three databases
Nl Nl Prevalence Nl Incidence Mt Mt Prevalence Mt Incidence Sb Sb Prevalence Sb Incidence
Rank Code Label p1000py EU 2005 p1000py EU2005 Rank p1000py EU 2005 p1000py EU2005 Rank p1000py EU 2005 p1000py EU 2005
1 A98 Prevention 171.4 175.6 97.9 99.0 2 111.6 131.8 90.4 107.7 50 5.3 4.6 4.5 3.9
2 W11 Family plan/oral contraceptive 93.0 93.7 12.6 13.1 127 2.3 – 1.5 – – 0.0 – 0.0 –
3 K86 Uncomplicated hypertension 75.7 79.2 5.3 5.5 7 41.1 59.9 4.6 6.2 1 114.1 79.8 19.3 14.4
4 S88 Contact dermatitis/other eczema 59.9 60.3 32.1 32.2 39 7.8 7.0 6.9 6.2 44 6.2 5.1 4.4 3.8
5 P06 Disturbances of sleep/insomnia 57.9 59.8 17.2 17.5 81 3.8 5.9 1.1 1.5 51 5.2 3.5 2.1 1.5
6 U71 Cystitis/other urine infection NOS 57.5 59.0 48.9 50.2 21 17.1 17.6 15.2 15.5 6 49.5 36.5 25.9 19.6
7 L03 Low back complaint excl radiation 55.7 56.9 41.0 41.7 90 3.5 3.7 2.6 2.8 43 6.4 4.7 2.5 2.0
8 R74 URI (head cold) 53.7 52.4 50.5 49.2 1 205.7 177.3 202.0 174.1 2 99.5 92.5 47.2 44.6
9 R05 Cough 50.6 50.1 42.3 41.8 10 27.6 24.3 23.0 20.3 96 2.3 2.4 1.4 1.6
10 R78 Acute bronchitis/bronchiolitis 48.6 48.2 41.8 41.3 6 43.4 41.7 42.0 40.0 5 50.7 44.9 25.5 23.0
11 A97 No disease 48.3 48.6 43.2 43.4 5 44.3 47.3 42.3 44.9 173 0.9 1.0 0.6 0.7
12 S74 Dermatophytosis 47.2 47.9 32.9 33.2 34 9.5 10.0 7.8 8.0 72 3.2 2.9 2.2 2.1
13 H81 Excessive ear wax 43.6 44.7 39.2 40.2 31 11.1 12.3 9.4 10.3 101 2.1 1.8 1.8 1.5
14 R96 Asthma 40.9 40.4 6.7 6.5 8 39.3 35.7 12.1 10.7 62 4.0 3.5 0.7 0.7
15 T93 Lipid metabolism disorder 39.4 41.4 7.5 7.9 14 21.6 28.8 9.1 11.4 17 19.6 14.9 11.1 8.6
16 R97 Hay fever/allergic rhinitis 38.7 39.0 8.8 8.8 11 25.4 23.2 10.0 9.0 209 0.7 0.7 0.4 0.4
17 A04 General weakness/tiredness 37.5 38.0 30.6 30.9 65 4.8 5.4 4.2 4.5 123 1.5 1.2 0.9 0.8
18 P76 Depressive disorder 36.1 36.9 10.1 10.2 15 21.4 25.8 6.7 7.5 31 9.7 7.1 2.4 1.8
19 R75 Sinusitis acute/chronic 35.9 35.9 30.8 30.8 16 20.8 18.8 18.3 16.3 27 10.9 9.9 5.0 4.5
20 A85 Adverse effect medical agent proper dose 35.8 36.9 30.7 31.6 17 20.8 24.0 14.5 17.5 361 0.2 0.2 0.1 0.1
24 T90 Diabetes non-insulin dependent 31.9 33.3 4.1 4.3 19 17.8 28.8 3.1 4.5 11 28.4 19.9 4.6 3.3
25 P01 Feeling anxious/nervous/tense 29.8 30.9 12.7 13.1 26 12.8 14.2 7.5 8.2 20 14.1 10.7 4.4 3.7
27 L86 Back syndrome with radiating pain 24.3 24.9 12.8 13.1 28 12.1 14.7 7.1 8.5 7 43.1 32.0 12.4 9.6
41 D87 Stomach function disorder 18.8 19.4 7.6 7.8 32 10.9 11.3 8.0 7.6 14 21.0 16.9 10.2 8.4
46 K85 Elevated blood pressure 16.4 17.0 8.0 8.2 38 8.1 9.9 5.7 7.2 9 42.3 30.1 8.7 6.8
48 D73 Gastroenteritis presumed infection 15.9 15.5 15.3 14.9 3 80.6 70.7 79.6 69.9 30 10.0 8.7 5.7 5.4
49 R76 Tonsillitis acute 15.5 15.3 14.7 14.5 9 34.4 26.9 32.4 25.4 12 25.6 29.0 13.8 15.5
54 K74 Ischaemic heart disease with angina 15.2 16.0 2.7 2.8 71 4.5 7.9 1.3 1.9 16 19.7 14.0 3.6 2.6
55 R77 Laryngitis/tracheitis acute 15.0 15.1 13.9 14.0 20 17.8 15.6 16.8 14.8 37 7.7 6.2 4.3 3.6
59 K77 Heart failure 14.4 14.9 3.5 3.6 62 5.1 10.4 2.0 3.9 19 14.3 10.2 2.7 2.0
77 L18 Muscle pain 11.1 11.4 7.3 7.4 4 45.0 48.1 40.5 43.2 270 0.4 0.3 0.2 0.2
83 K87 Hypertension complicated 10.3 10.9 0.5 0.5 98 3.3 6.2 0.2 0.3 13 23.2 15.3 4.2 2.7
88 R80 Influenza 9.6 9.6 9.4 9.4 12 25.2 22.8 24.8 22.3 97 2.2 2.0 1.3 1.2
118 P17 Tobacco abuse 7.6 7.7 4.4 4.5 18 19.9 21.3 1.5 1.5 39 7.2 7.3 6.4 6.5
102 P74 Anxiety disorder/anxiety state 8.8 8.9 2.0 2.0 24 14.7 18.3 3.8 4.2 3 60.5 44.3 19.1 14.7
128 L83 Neck syndrome 6.9 7.1 2.4 2.5 74 4.3 4.4 3.4 3.4 8 42.5 30.8 11.8 9.1
162 L84 Back syndrome without radiating pain 5.2 5.4 1.2 1.3 141 2.0 2.8 1.0 1.3 4 52.9 39.7 14.2 11.8
226 D85 Duodenal ulcer 3.4 3.5 0.6 0.6 415 0.2 0.3 0.0 – 10 35.1 26.2 11.2 8.6
267 K80 Cardiac arrhythmia NOS 2.6 2.7 1.0 1.0 479 0.1 0.2 0.0 – 15 20.3 14.6 4.7 3.7
282 R79 Chronic bronchitis 2.4 2.5 0.5 0.5 188 1.3 2.0 0.5 0.7 18 19.3 14.5 4.7 3.5
441 R29 Respiratory symptom/complaint other 0.7 0.7 0.6 0.6 13 24.4 22.2 23.6 21.3 240 0.5 0.5 0.2 0.3
41 ranks Total Episodes of care (p1000py) 3503.2 2130.1 1731.4 1281.0 1419.1 566.5
Proportion top 20 EoC of whole distribution 32% 51% 56%
Nl, Netherlands; Mt, Malta; Sb, Serbia. The 20 most commonly coded EoCs in all three databases are presented. The prevalence rate (rate of that EoC per 1000 patient years and the title representing the diagnosis at the end of an EoC) and incidence rate
(rate of that EoC per 1000 patient years and the diagnostic title in this case being that at the start of a new EoC) of the 41 EoC rubrics (presented as a disease label or symptom, i.e. ICPC Components 1 and 7) that describe the 20 most common EoCs in the
all three populations are given. Rates are expressed per 1000 patient years of observation, both non-adjusted and adjusted for age and sex to a standardized EU 25 country population. The ranking of each rate in the three respective populations is given
(according to their rank in prevalence), and the rubrics are ranked according to the Dutch distribution (ranking in first column). The percentage of all EoCs, which are coded by the top 20 most used rubrics in each distribution is given in the bottom row.
‘Rank’ gives the rank of that rubric in the distribution of prevalent EoCs in that population. ‘Code’ gives the ICPC code. ‘Label’ gives the ICPC-2 text label for that rubric. ‘Prevalence’ gives the rate of observation of that rubric as an EoC title (both
unadjusted and adjusted for age and sex against the EU-25 population). ‘Incidence’ gives the rate of observation of that rubric as a title of new EoCs (both unadjusted and adjusted for age and sex against the EU-25 population). ‘Total Episodes of care (per
1000 py)’ gives the total rate of EoC, incident and prevalent, per 1000 patient years. ‘Proportion top 20 EoC of total distribution’ gives the percentage proportion that these top 20 EoC titles represent, of the total distribution of EoCs.
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EoCs for ‘disease label’ diagnoses (Component 7 ru-
brics in ICPC) with rather more specifically defined di-
agnostic criteria, such as anxiety disorder (P74), neck
syndrome (L83), back syndrome (L84), duodenal ulcer
(D85), cardiac arrhythmia NEC (K80), elevated blood
pressure (K85) and chronic bronchitis (R79). This is
even more remarkable due to the relatively lower
prevalence of other EoCs in the Serb database com-
pared with the other two datasets.
There were many examples with similar incidence
or prevalence (adjusted for age and sex), or both, in
two or more populations. These include hypertension
(K86), acute bronchitis (R78), stomach function disor-
der (proven by investigation, D87), acute tonsillitis
(R76), diabetes (T90), lipid disorder (T93), back syn-
drome with radiating pain (L86), ischaemic heart dis-
ease with angina (K74), heart failure (K77) and
complicated hypertension (K87). Anxiety disorder
(P74) exhibited rather similar incidence and preva-
lence in the first two databases but is then more preva-
lent in the Serb database.
Extended comparison of incidence and prevalence rates
Table 6 is an extended comparison of incidence and
prevalence rates, which illustrates the increased accu-
racy with use of an EoC data model. The prevalence
and incidence rates of an extended selection of condi-
tions with strict coding definitions, which may not
have been included in a top 20 distributions, and also
of mental health, skin, cardiovascular chapters in
ICPC are given. These rates are broadly similar be-
tween the three populations and in some cases almost
precisely so.
Discussion
Summary
First research question. This study describes the con-
tent of general practice/FM as characterized by the
Transition Project databases, collected from the daily
care of selected practice populations in Malta, the
Netherlands and Serbia and more specifically as charac-
terized by the distributions of RfEs, interventions and
diagnoses within EoCs. Distributions of utilization and
incidence and prevalence rates are indicative but do
not allow in depth interpretation of the doctor–patient
relationship and the content of the consultation.
Second research question. The distributions allow the
identification of interesting differences and similarities,
due to complex effects which are impossible to disag-
gregate, including patient needs, burden of disease, so-
cio-economic and demographic realities, culture, health
beliefs and the strong effects of different health care
systems, besides individual FD approaches, experience
and training. Nevertheless, striking similarities were
identified in many of the distributions, and the com-
monalities may be considered to be more striking than
the contrasts.
Observed similarities and differences in the distribu-
tions of RfEs, interventions and diagnoses, within EoCs
in these practice populations provide ample opportu-
nity for reflection in the discussion of these results be-
low. However, notwithstanding such differences, generic
similarities in the content and practice of general prac-
tice/FM in these practice populations emerge and lend
limited support to the existence of an international
discipline of FM.
TABLE 6 Is an extended comparison of incidence and prevalence rates of selected EoCs (episode titles) and ICPC chapters, population by population
The Netherlands Malta Serbia
Incidence Prevalence Incidence Prevalence Incidence Prevalence
Diagnosis Rate Standardized Rate Standardized Rate Standardized Rate Standardized Rate Standardized Rate Standardized
T90—diabetes type II 4.1 4.3 31.9 33.3 3.1 4.5 17.8 28.8 4.6 3.3 28.4 19.9
K86—hypertension 5.3 5.5 75.7 79.2 4.6 6.2 41.1 59.9 19.3 14.4 114.1 79.8
U95—renal stone 2.0 2.1 4.5 4.7 3.4 3.5 5.4 5.9 3.7 3.0 6.7 5.3
D98—cholecystits/lithiasis 2.1 2.1 4.8 5.0 2.0 2.3 3.6 4.5 3.2 2.3 5.3 3.7
S70—herpes zoster 3.9 4.0 5.1 5.2 1.5 1.9 1.7 2.2 1.1 0.8 1.4 1.1
A72—chicken pox 2.4 2.2 2.5 2.3 4.9 3.7 5.4 4.1 0.7 1.3 0.8 1.6
P70—dementia 0.7 0.8 2.8 2.8 0.1 0.2 0.5 1.1 0.2 0.3 0.7 0.6
P72—schizophrenia 0.1 0.1 1.4 1.4 0.0 – 0.5 0.7 0.3 0.3 2.6 2.8
All Chapter P Component 7 21.0 21.3 69.6 70.7 12.2 13.5 42.5 51.5 23.3 18.3 81.0 61.5
All Chapter P 80.5 81.4 206.4 210.5 31.0 34.0 95.6 110.6 38.7 32.2 113.3 88.0
All Chapter S 320.1 319.8 457.4 459.3 110.2 109.6 132.4 132.5 45.3 40.4 72.1 61.3
All Chapter K 76.7 79.1 275.2 286.2 35.9 48.5 104.4 153.5 66.4 49.4 294.4 208.1
Rates are given per 1000 patient years, both unstandardized and also adjusted for age and sex to the EU25 population (2005). Rates for diabetes
(Dutch data include type I), hypertension, nephrolithiasis, cholecsystitis, herpes zoster, varicella, dementia, schizophrenia, all mental health (ICPC
Chapter P labels), skin (Chapter S) cardiovascular (Chapter K) and ‘disease label’ mental health (Chapter P, Component 7) problems are given.
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Third research question. Being subject to myriad ef-
fects, which cannot be separated, the observed similar-
ities in these distributions lend only modest support to
the hypothesis of an international academic discipline
of FM. Further analysis to shed additional light should
include a study of the process of diagnosis in FM, and
this is performed in a companion article in this se-
ries.25
Population
The over-representation of male children and young
women in the Maltese and (less so) Dutch practice
populations (Fig. 1) is a typical effect of a relative ten-
dency of higher patient contact rates in these groups.
The sad effects of war on the Serb population are evi-
dent from the distribution, besides the effect of FDs
not being ‘allowed’ to care for children <15 years.
Coding
The pattern of ICPC utilization (Table 3) indicates
that Dutch FDs use ICPC in a more comprehensive
way, but this comparison is rather limited by the fact
that the Serb database covers only 1 year of observa-
tion. There is more consistency across populations in
coding RfEs, when compared to EoCs, even though
both are coded with the same range of ICPC rubrics.
Utilization
Generally speaking, there are larger differences in the
distributions of utilization than in the distributions of
RfEs and EoCs. For example, the Maltese data (Table 2)
indicate relatively fewer contacts per patient year,
and this may indicate a relative lack of continuity of
care in Malta due to the absence of a patient regis-
tration system. In fact, a larger proportion of EoCs
in the Maltese database contain only one encounter
compared with the other two databases (data not
tabulated). This is also a reflection of a tendency for
filling out repeat prescriptions for free in Maltese
Government dispensaries rather than with the pri-
vate FD against additional payment. The Serb data
tend to show more problems managed per encounter
(subencounters, or diagnoses, per encounter) but rel-
atively fewer new problems (EoC) per patient year.
The Serb FDs thus seem to focus on the care for
chronic, rather than new, health problems. The
Dutch data, with more data per contact and per
EoC, probably represent a good example of com-
plete data recording in a patient population, which
goes to their FD for most of their care.
Interventions
The Dutch FDs seem to perform more interventions
per patient year (Table 2), but the variability of inter-
vention rates per EoC across populations is less, indi-
cating that much of the variability is explained by
Dutch FDs seeing more problems per patient year. This
pattern is the same for prescriptions (Serb data are un-
available).
Reasons for encounter
The distributions of incident and prevalent RfEs in the
three populations (Table 4) also exhibit similarities and
differences. The differences observed may be plausibly
explained by various interacting effects, as outlined in
the ‘Summary’ section above. For example, the cultural
approach to tiredness as a medical complaint in the
Netherlands,26 the requirement for sickness certificates
from a doctor from the first day of illness in Malta16
and the effects of post-traumatic stress and of demo-
graphic change due to war in Serbia may all be linked
to differences in the observed incidence and prevalence
of the respective RfEs. Serb FDs had to refer any gy-
naecological problems and all children.
However, many striking similarities in incidence or
prevalence rates, or both, are evident between two or
three of these populations, even when adjusted for age
and sex. Examples include cough (R05), abdominal
pain (D01), earache (H01), headache (N01), chest com-
plaints (L04), urinary symptoms (U01 and U02) and
red eye (F02). Another striking similarity is that the
common top 20 distributions in these three populations
are described using only 36 ICPC rubrics, and these 20
rubrics describe the majority (66%, 64% and 83%, re-
spectively) of the total number of RfEs presented to
the FDs. In general, there is indeed remarkable overlap
in the distribution of RfEs in these three populations.
Episode titles
In the distribution of EoCs, listed by their episode la-
bel (Table 5), the prevalence and incidence rates of
the selected top 20 (prevalent) EoC rubrics exhibit
similarities and differences, as seen with the distribu-
tions of RfEs.
In fact, there is a distinct trend for relatively higher
incidence and prevalence of various EoCs in the Mal-
tese and Dutch databases, in correspondence with
a complementary phenomenon (Table 4) with respect
to higher prevalence of the symptoms and complaints
(RfEs) associated with these diagnoses. This evidently
reflects an effect of FDs addressing patient needs, ex-
pressed as RfEs.
Independent of this phenomenon, the incidence and
prevalence of many other EoCs were remarkably simi-
lar, especially with respect to ‘disease label’ ICPC
Component 7 diagnoses (as against ‘symptom label’
Component 1 diagnoses).
Similarities and differences
As explained above, the observed differences may be
due to various effects, including FD attitudes to cod-
ing (e.g. Serb doctors seem to record fewer new EoCs
in general), patient requests (e.g. higher incidence and
prevalence of RfEs associated with respiratory and
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acute viral illness in Malta were also reflected in the
respective EoCs such as R74) and system effects (e.g.
disease-specific health promotion or prevention pro-
grammes or guidelines, different systems for repeat
prescriptions, the fact that the Serb primary care sys-
tem was a new and possibly relatively weaker system,
etc.) but also hard epidemiological differences, such
as the Dutch FDs being involved with many more
EoCs for family planning, practically non-existent in
Malta and Serbia due to cultural and religious reasons.
Serb FDs were less involved in prevention (A98)
and administrative paperwork (part of A97), possibly
reflecting the involvement of practice nurses in these
activities, and a tendency for the latter not to code all
that was done in the practice. There appeared to be
a preference of Serb FDs for disease label diagnoses
over symptom diagnoses, in contrast to their Dutch
and Maltese colleagues. This may be a vestige of their
antecedent experience with using International Classi-
fication of Diseases (ICD) version-10 (which makes
coding a symptom diagnosis much more difficult) ex-
clusively in a hospital setting until this pilot project
started. The high prevalence of P74 (anxiety disorder)
in the Serb database is expected due to the recent ef-
fects of war, but the low prevalence of P76 (depres-
sion) is remarkable in contrast.
The incidence and prevalence rates of a number of
disease label diagnoses with strict coding criteria were
remarkably similar between the three databases. The
prevalence of hypertension, for example (Table 5), was
very similar in the three databases, but slightly lower in
Malta, where there may be an effect of the loss of conti-
nuity of care with repeat prescriptions being issued at
Government clinics. However, these rates still compare
far better between them than equivalent data from pop-
ulation-based epidemiological studies of the prevalence
of hypertension in Europe and the rest of the world.27
Validation through extended comparison of incidence
and prevalence rates
This latter point is further explored in the extended
comparison of incidence and prevalence rates of se-
lected EoCs (episode titles) and International Classifi-
cation of Diseases (ICD) version chapters (Table 6).
Many of these rates are strikingly similar; for example,
renal stone and cholecsytitis/lithiasis rates were more
consistent between the three datasets than those for
herpes zoster, which is often quoted as a useful stan-
dard comparator rate to check for denominator prob-
lems in EMR databases.
The standardized prevalence of diabetes was also
quite similar in all three databases, although it might
be expected to be higher in Malta compared with
the Netherlands. However, in another study based on
the same Transition Project data, the standardized
incidence and prevalence of diabetes (calculated using
the number of people consulting per year as the
denominator and standardized to the Maltese popula-
tion to estimate a population, and not practice popula-
tion, prevalence) were almost identical to those
derived from a population-based epidemiological
study of diabetes in Malta by Schranz in the 1980s.17,28
The rates for skin and cardiovascular conditions vary
between databases, possibly reflecting real population
differences as well as health care system priorities for
prevention activity. The low rate for cardiovascular dis-
ease (Chapter K of ICPC) measured in the Mediterra-
nean island Malta is understandable but may also
partly reflect failure of continuity of care (see above).
In contrast, the low rate of skin conditions (chapter S)
in Serbia seems to be due to readily accessible self-
referrals to secondary care specialists working in the
same community health centres with the FDs.
The trend for rates of disease label diagnoses to be
generally similar was also evident in the mental health
chapter of ICPC (Chapter P). In contrast, the rates
for all mental health chapter EoCs including symptom
diagnoses (Components 1 and 7 together) are strik-
ingly different. This divergence is therefore due to dif-
ferences in the rates for symptom diagnoses. An
example of this could be a diagnosis of sadness (P03),
or anxiety (P01), due to the symptom not fulfilling Di-
agnostic Statistical Manual of Mental Disorders (ver-
sion 4, DSM-IV) criteria to allow a diagnosis of
depression (P76) of anxiety neurosis (P74) to be made.
It seems that such a practice is more prevalent in the
Netherlands, and this inflates the prevalence of ‘all
mental health problems’ (ICPC Chapter P) due to in-
clusion of milder conditions with a symptom diagnosis.
The similarities in the extended comparisons in
Table 6 support the accuracy of our EoC data model
and increase our confidence in our findings.
Comparison with existing literature
The literature on international comparisons of EMR
data collected from FM is limited, notwithstanding the
long tradition of such studies in the UK and the Nether-
lands. The trend is for data to be aggregated from FD
practices treated as a population sample, with the aim
to enhance generalizability of derived statistics to the
general population and consequently inform public
health policy. FD practices are consequently selected
with a focus on generalizability and representativeness,
and inter-practice variation is considered to be a bias
rather than a real phenomenon to be studied. The direct
applicability of such data to day-to-day FD care is lim-
ited, due to the emphasis on population prevalence of
specific diseases rather than data, which can be applied
clinically. Additionally, precious few international
comparisons of these databases have been published.
One notable exception was the electronic health in-
dicator data (eHID) project, which compared incidence
and prevalence data of indicator diseases collected from
FM EMR databases in eight European countries,
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including the Transition Project data from Malta.17
The rates for the incidence and prevalence of diabetes
and ischaemic heart disease were quite comparable
(e.g. the prevalence of diabetes was estimated to range
between 22.3 and 64.6 per 1000, with Malta and Italy
having comparable rates at the top of the range). How-
ever, the data for mental illness prevalence were strik-
ingly different, ranging from 18 to 200 per 1000 from
Belgium to France. This anomaly was due to a weakness
of the data collected, due to the different classifications
used in different countries, along with an inability to cap-
ture episode typing of data. The Component 7 mental
health chapter rates we report (Table 6) are much more
consistent and illustrate how the use of ICPC and an
EoC data model would have allowed a much more ac-
curate picture to be obtained in the eHID project.17
The study by Okkes et al. using ICPC from three
countries, and data collected using ICD-9 from the
USA, also found important differences and striking simi-
larities between databases. Differences in the numbers
of EoC and of encounters per patient per year were
small compared with differences in utilization per EoC,
including diagnostic and therapeutic interventions. Simi-
larities between the databases were much better re-
flected by the way patients formulate their demands for
care (RfEs) rather than the diagnoses made by the FD.9
These findings are very similar to those we report here.
Boerma10 reports on differences in rates of utiliza-
tion and process between family practice populations
in different European countries. He comes to the con-
clusion (p. 164) that most of the variation in such rates
could be explained by the effects related to the health
care system rather than due to the effects of doctors
and practices (practice populations). We also observed
larger differences between utilization and process
rates as against distributions of EoCs, and even less so
for distributions of RfEs. We thus agree with the con-
clusion of Boerma that the influence of the health care
system on the ‘task profile’ of FM seems to have
a larger effect on utilization as against distributions of
EoCs and patient needs for care. This has an implica-
tion of the internationality of FM—health care system
differences seem to affect what doctors do but have
less effect on what patients request or on which EoCs
actually happen. As such, the effects of health care
system differences are related more to FD activity
and related less to the core aspects of the practice
of the discipline of FM. This phenomenon is also
reflected in the commonalities we found between
the processes of diagnosis in different populations in
a related study in the series.25
Generalizability
The generalizability of data collected from a group of
practices may theoretically be improved by adjusting
mean effect estimations for variation across clusters,
to correct for inter-doctor and inter-practice variation.
This is an appropriate approach when one conceptual-
izes such practice populations as unbiased cluster sam-
ples of a larger population under study, such as in
public health studies. In such a case, inter-doctor vari-
ation may be considered to be an undesirable feature
of the data.
However, this study conceptualizes the practice of
FM as a complex adaptive system, based on a caring
relationship between an FD, or group of FDs, and
a population of patients that tends to be stable over
time. In this case, the effect of the individual doctor is
a core element of the data thus collected, and the ef-
fect is not considered at all as a bias.
Adopting this latter model has at least two major
implications. One is that the analysis of a component
of the system in isolation has limited generalizability
to the whole, due to the non-linear properties of
complex systems (often called the ‘butterfly effect’),
and this limitation cannot be overcome through sta-
tistical methods, which simply widen the confidence
interval of an observation.29 Secondly, components
of the variation of observed rates between popula-
tions are also complex, being composed of multiple in-
teracting effects as explained above (e.g. age, sex,
geographical location, culture, socio-economic status,
co-morbidity, inter-doctor variation, changing evidence
base over time, etc.).
FDs are often selected to participate in EMR re-
search after they have accepted to record such data
carefully, and in depth, over time. Therefore, these
FDs are often not representative of FDs in a national
system, but rather tend to collect data at a higher level
of detail and accuracy than their colleagues, and may
have an incentive to do so, be it financial or academic.
Thus, the analysis of such data exhibits many of the
qualities and limitations of both qualitative and quan-
titative research methodologies, sacrificing some gen-
eralizability for depth and accepting inherent features,
which cannot be adjusted for mathematically without
introducing new systematic errors and biases.
Studies of EMR data are complementary to epide-
miological surveys and are not necessarily less valid
or less generalizable. A recent study by Esteban-
Vasallo et al. comparing observations based on EMR
data from FDs within a national epidemiological sur-
vey concluded that both perspectives are different but
complementary. One is not inherently superior to the
other, at least with respect to estimating the preva-
lence of chronic diseases.30 A similar conclusion was
recently reported by Barber et al.,31 who found that
epidemiological surveys based on self-reports are not
necessarily better than FM EMR studies of prevalence
rates, especially for less well-defined diagnoses.
Limitations
The three databases were selected since these data were
available, current and contained data on both RfEs and
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diagnoses within an EoC structure. These data were col-
lected for research purposes from selected practices,
with the exception of Serbia, and may not necessarily
be generalizable to the populations of these three coun-
tries as a whole. A comparison of data from more coun-
tries, had they been available, would have allowed
a more powerful international comparison. One key
message from this study is that more data are needed
for such comparisons, and this research should be ex-
tended to other countries.
The Serb FDs were recruited fresh out of a hospital
environment into a foreign ICRC programme, chosen
to join a fledgling primary care system and use innova-
tive information technology and a new classification.
Their motivation may have been very different to the
other FDs in this research project. The quality of data
recording may suffer when it is collected by larger
numbers of less motivated doctors. This may have
been the case in Serbia, where doctors did not volun-
teer. However, these data afforded perspectives on
a system with complete coverage of a whole munici-
pality in the South of the country. The Serb rate of
RfEs per new EoC is less than unity, indicating that
some new EoCs were recorded without any RfE at
all, reflecting a failure of software error trapping.
Some of the Dutch Transition Project FDs were re-
munerated to participate in the project, but many con-
tinue to record data even though the funding had
formally stopped. The Maltese FDs volunteered to join
the project and had to pay to support development of
the software to their particular needs. The practice
population in Malta represents a population of patients
consulting over a 5-year period with private FDs. Most
patients in a practice will consult at least once in such
a time frame. Most Maltese have a relationship with
one private FD, but a minority of patients use the gov-
ernment health centres as their main provider, and we
had no access to data from these clinics.
An additional source of differences is represented
by the fact that the Dutch database contains more re-
peat prescriptions. The incidence and prevalence rates
for some EoCs (for example A98, W11, P06, data not
tabulated) could have been different should the data
have been analysed separately by type of encounter
(say, excluding repeat prescriptions). However, this
would only partly explain the observed differences
since the Dutch rates for many EoCs during face-to-
face encounters would still have been considerably
higher than the Maltese, and especially the Serb, rates.
For example, family planning with oral contraceptives
is indeed far more common in the Netherlands, inde-
pendent of the effect of repeat prescriptions. Analy-
sing data by different types of encounter (say,
excluding repeat prescriptions) would also reduce
the power of the database, and amplify differences
due to system effects (such as different procedures
for obtaining repeat prescriptions between systems),
and different preferences for a home visit for certain
conditions in different practices.
This was a study of EoCs, and not episodes of illness,
in the community. Should the distribution of episodes
of illness be similar between these three countries, nev-
ertheless the distributions of EoCs might be very differ-
ent. For example, the prevalence of EoCs for otitis
media in the Netherlands is declining as patients come
to understand that they are less likely to get an antibi-
otic from their FD, due to current treatment guide-
lines. Patients are therefore less likely to attend for
this condition, even though the illness may be as prev-
alent as in the past. In this case, the prevalence of
EoCs is decreasing due to a health care system effect,
independently of actual disease prevalence. Rather
than a limitation, however, this is actually a different
perspective of a complex reality.
Strengths
The fact that the EMR TransHis guides and supports
the doctor during coding, providing ICPC coding crite-
ria and software error trapping, improves the quality
of the data collected, which in turn improves its reli-
ability.
The software and classification system provide data,
which allow the calculation of precise incidence and
prevalence rates of both EoCs and RfEs in these pri-
mary care populations from these three countries. The
use of an EoC model corrects for diverse artefacts of
observation, including the effect of multiple consulta-
tions for the same problem, and this allows the correct
interpretation of multiple incident episodes in one in-
dividual in a defined period of observation. This has
been validated using the data in Table 6.
Other artefacts, such as the paradoxical increase in
incidence in the very old (>85 years of age) due to
high mortality rates, are adjusted for by the accurate
patient–year denominator in this project.
These qualities of these databases are a substan-
tial strength, which supports the conclusions of this
study.
Conclusions
In this study, we describe differences in the distribu-
tions of utilization, RfEs and EoCs in the Transition
Project patient populations. These reflect cultural,
socio-economic, religious, spiritual and health care sys-
tem effects, beside inter-doctor variation in care pro-
cesses and attitudes to care, and actual population
differences in the incidence and prevalence of diseases
or health problems. We could not tease out individual
effects. However, we found modest evidence of both
an international and a local FM content, reflected by
important similarities in these distributions, at least
with respect to overlap in the actual content of FM
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practice reflected in distributions of RfEs and EoCs,
less so in distributions of utilization.
Data which are not collected within an episode-
based model are less able to characterize incidence
and prevalence rates since the rates are not corrected
for the effect of multiple encounters for one health
problem. Incidence and prevalence, two classical
epidemiological indicators, allow exploration of the
similarities and differences between different FM
populations, but they do not reflect the content of
the doctor-patient encounter beyond a superficial
perspective.
FM is a complex discipline, and the reduction of the
content of a consultation into one or more medical diag-
noses, ignoring the patient’s RfE, is a coarse reduction,
which lacks power to fully characterize a population’s
health care needs. In fact, RfE distributions seem to be
more consistent between populations than distributions
of EoCs are, in many respects.
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